Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | CYP1A1 | P04798 | 6/20 | 0.50 |
| ▸ | CYP1B1 | Q16678 | 6/20 | 0.50 |
| ▸ | AHR | P35869 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.44 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.44 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.44 |
| ▸ | CYP4B1 | P13584 | 2/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 2/20 | 0.44 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.44 |
| ▸ | CYP2A7 | P20853 | 2/20 | 0.44 |
| ▸ | CYP3A7 | P24462 | 2/20 | 0.44 |
| ▸ | CYP2F1 | P24903 | 2/20 | 0.44 |
| ▸ | CYP2C18 | P33260 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | CYP2J2 | P51589 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1816933 | 0.97 | ALDH1A1 (0.65) | ALDH1A1CYP1A1CYP1B1AHRCYP3A4 | |
| SCHEMBL811578 | 0.94 | ALDH1A1 (0.59) | ALDH1A1CYP1A1CYP1B1AHRCYP3A4 | |
| SCHEMBL15521815 | 0.85 | ALDH1A1 (0.50) | ALDH1A1CYP1A1CYP1B1AHRCYP3A4 | |
| SCHEMBL12231 | 0.84 | ALDH1A1 (0.48) | ALDH1A1CYP1A1CYP1B1AHRCYP3A4 | |
| SCHEMBL19088278 | 0.83 | ALDH1A1 (0.48) | ALDH1A1CYP1A1CYP1B1AHRCYP3A4 | |
| 1,3,5-Trimethoxybenzene SCHEMBL28493 | 0.83 | ALDH1A1 (1.00) | ALDH1A1CYP1A1CYP1B1AHRCYP3A4 | |
| SCHEMBL15936165 | 0.82 | ALDH1A1 (0.46) | ALDH1A1CYP1A1CYP1B1AHRCYP3A4 | |
| SCHEMBL1477524 | 0.82 | ALDH1A1 (0.46) | ALDH1A1AHRNQO2 | |
| SCHEMBL440836 | 0.82 | CYP3A4 (0.50) | ALDH1A1CYP1A1CYP1B1CYP3A4CA1 | |
| SCHEMBL7667026 | 0.82 | ALDH1A1 (0.46) | ALDH1A1CYP1A1CYP1B1AHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 410 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119574738-A | Method for detecting related substances in trimethylphloroglucinol | 河北广祥制药有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119555839-A | Method for simultaneously measuring pharmaceutical grade intermediate 1,3, 5-trimethoxybenzene and related impurities | 江苏宝众宝达药业股份有限公司 | 2025-03-04 | — | — | CN | claimed |
| CN-116813454-B | Synthetic method of pterostilbene | 珠海市柏瑞医药科技有限公司 | 2024-03-22 | — | — | CN | claimed |
| CN-117430569-A | Synthesis method of 4, 6-dinitro-5, 7-diaminobenzofuroxan and 1,3, 5-triamino-2, 4, 6-trinitrobenzene | 中国工程物理研究院化工材料研究所 | 2024-01-23 | — | — | CN | claimed |
| CN-113264837-B | Energetic ion salt of 3, 5-dihydroxy-2, 4, 6-trinitrobenzene derivative and preparation method thereof | 信阳师范学院 | 2023-09-29 | — | — | CN | claimed |
| CN-116813454-A | Synthetic method of pterostilbene | 珠海市柏瑞医药科技有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-113054253-B | Overcharge-proof electrolyte of lithium ion battery | 江西格林德能源有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-113264837-A | Energetic ionic salt of 3, 5-dihydroxy-2, 4, 6-trinitrobenzene derivative and preparation method thereof | 信阳师范学院 | 2021-08-17 | — | — | CN | claimed |
| CN-113054253-A | Overcharge-proof electrolyte of lithium ion battery | 江西格林德能源有限公司 | 2021-06-29 | — | — | CN | claimed |
| WO-2021096496-A1 | METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2021-05-20 | — | — | WO | claimed |
| EP-3790862-A2 | METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS | Colorado State University Research Foundation (US) | 2021-03-17 | — | — | EP | claimed |
| CN-112262128-A | Method for forming aryl carbon-nitrogen bond by illumination and photoreactor for carrying out the reaction | 科罗拉多州立大学研究基金会 | 2021-01-22 | — | — | CN | claimed |
| US-20200147581-A1 | METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2020-05-14 | — | — | US | claimed |
| WO-2020036661-A2 | METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2020-02-20 | — | — | WO | claimed |
| US-20190345122-A1 | METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2019-11-14 | — | — | US | claimed |
| EP-1326613-A1 | USE OF SUBSTITUTED IMIDAZO 1,2-A]PYRIDINE-, IMIDAZO 1,2-A]PYRIMIDINE AND IMIDAZO 1,2-A]PYRAZINE-3-YL-AMINE DERIVATIVES FOR PRODUCING NOS-INHIBITING MEDICAMENTS | Grünenthal GmbH (DE) | 2003-07-16 | — | — | EP | claimed |
| WO-2002030428-A1 | USE OF SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE-, IMIDAZO[1,2-A]PYRIMIDINE AND IMIDAZO[1,2-A]PYRAZINE-3-YL-AMINE DERIVATIVES FOR PRODUCING NOS-INHIBITING MEDICAMENTS | Grünenthal GmbH (DE) | 2002-04-18 | — | — | WO | claimed |
| CN-118271158-B | Method for synthesizing deuterium-labeled substance containing deuterium atom structural unit | 山东大学 | 2026-05-12 | — | — | CN | disclosed |
| EP-0248420-A2 | Benzopyran derivatives | DAIICHI SEIYAKU CO., LTD. (JP) | 1987-12-09 | — | — | EP | disclosed |
| US-4673746-A | DIURETICS, HYPOTENSIVES | HOECHST-ROUSSEL PHARMACEUTICALS, INC. (US) | 1987-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345122-A1 | METHODS FOR FORMING ARYL CARBON-NITROGEN BONDS USING LIGHT AND PHOTOREACTORS USEFUL FOR CONDUCTING SUCH REACTIONS | TYR, CRY2, CRY1 | ALDH1A1 1574/4885CYP1A1 554/4885CYP1B1 530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.